Elmwood Wealth Management, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Elmwood Wealth Management, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,146,967
-22.5%
67,8990.0%1.04%
-19.8%
Q2 2023$2,768,922
+9.4%
67,8990.0%1.29%
+8.0%
Q1 2023$2,530,596
+6.8%
67,8990.0%1.20%
+1.0%
Q4 2022$2,368,996
-37.7%
67,8990.0%1.18%
-37.6%
Q3 2022$3,800,000
+8.1%
67,8990.0%1.90%
-5.1%
Q2 2022$3,514,000
-28.5%
67,899
+0.4%
2.00%
-20.7%
Q1 2022$4,912,000
-38.2%
67,599
+0.6%
2.52%
-33.6%
Q4 2021$7,943,000
-27.0%
67,1740.0%3.79%
-33.9%
Q2 2021$10,876,000
+101.7%
67,1740.0%5.73%
+74.2%
Q1 2021$5,391,000
+299.3%
67,174
+4.6%
3.29%
+200.4%
Q3 2020$1,350,0000.0%64,2040.0%1.10%0.0%
Q2 2020$1,350,000
-99.9%
64,204
+30.7%
1.10%
+10.5%
Q1 2020$1,036,320,000
+109912.7%
49,138
-23.5%
0.99%
+20.7%
Q4 2019$942,000
-45.5%
64,204
-50.4%
0.82%
-53.0%
Q3 2019$1,728,000
-20.7%
129,439
-2.8%
1.75%
-9.3%
Q2 2019$2,180,000
-6.7%
133,144
-2.7%
1.93%
-10.8%
Q1 2019$2,337,000
+177.9%
136,849
+122.1%
2.16%
+166.0%
Q4 2018$841,000
-100.0%
61,622
-5.7%
0.81%
-47.7%
Q3 2018$1,869,659,000
+13.2%
65,327
+8.3%
1.55%
+3.3%
Q2 2018$1,650,957,000
+59.3%
60,342
+22.8%
1.50%
+51.6%
Q1 2018$1,036,320,00049,1380.99%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Discovery Value Fund 572,950$19,990,2265.79%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$39,952,2255.34%
MPM BioImpact LLC 455,238$15,883,2544.12%
ARK Investment Management 9,420,782$328,691,0842.85%
Atlas Venture Associates IX, LLC 10,000$348,9001.74%
Ghisallo Capital Management LLC 250,000$8,722,5001.55%
Nikko Asset Management Americas, Inc. 2,976,002$103,743,4301.49%
Prosight Management, LP 72,116$2,516,1271.37%
Rokos Capital Management LLP 826,063$28,391,7851.24%
Elmwood Wealth Management, Inc. 67,899$2,368,9961.18%
View complete list of INTELLIA THERAPEUTICS INC shareholders